Nobilis® Rismavac
Nobilis Rismavac consists of a suspension of living cultured avian cells containing attenuated Marek's Disease virus.
Presentation
Deep frozen suspension for injection after reconstitution in diluent. The vaccine is supplied in frozen ampoules held in metal canes stored in a liquid nitrogen canister. Solvent CA is supplied for reconstitution of the vaccine prior to use.
Active ingredients
Per dose:
Live cell associated Marek’s Disease virus strain CVI988 ≥ 3.0 log10 TCID50
Target species
Chickens
Indications for use
For the vaccination of chickens against Marek’s disease.
Withdrawal periods
Zero days
Packaging
Ampoules containing 1000 or 2000 doses supplied together with Solvent.
Legal category
POM-VPS
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: November 2025
